P. Schaefer

发表

An EORTC phase I study of capecitabine (Xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer.

M. Piccart, H. Bonnefoi, L. Mauriac, 2003, European journal of cancer.

A randomized phase II trial of amonafide or trimetrexate in patients with advanced non‐small cell lung cancer. A trial of the north central cancer treatment group

J. Jett, J. Krook, R. Morton, 1993, Cancer.

Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia.

M. Loh, M. Kahn, N. Heisterkamp, 2011, Blood.

An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer

M. Piccart, H. Bonnefoi, L. Mauriac, 2001, Breast Cancer Research and Treatment.

A randomized trial comparing axillary clearance versus no axillary clearance in older patients (≥ 60 years) with breast cancer: First results of International Breast Cancer Study Group Trial 10-93.

J. Forbes, D. Zahrieh, D. Crivellari, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.

M. Loh, N. Heisterkamp, H. Koo, 2013, Blood.

DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary Tract

G. Kristiansen, H. Gevensleben, D. Dietrich, 2016, PloS one.

Phase II Trial of S-1 as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer

R. Govindan, R. Herbst, J. Schiller, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Treatment decisions in elderly breast cancer patients

C. Cobau, W. Eggleston, A. Konski, 1995 .

Adjuvant CD49d Blockade Eradicates Chemoresistant ALL

M. Loh, N. Heisterkamp, H. Koo, 2010 .

Malignant islet cell tumor associated with hypercalcemia.

J. Howard, P. Schaefer, Kitai Kim, 1995, Surgery.

Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia.

M. Kahn, N. Heisterkamp, W. Hofmann, 2011, Blood.

Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.

N. Heisterkamp, H. Koo, W. Hofmann, 2013, Blood.

Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs

R. Petersen, J. Sloan, A. Jatoi, 2004, Supportive Care in Cancer.